CPL Lead Buying Priced on What Happens After the Form

Cost per lead is not a price you can act on. A forty euro lead with an eleven percent contact rate costs three hundred and sixty-four euros per conversation, and a ninety euro lead that answers the phone half the time is cheaper. Every buy I run is priced against a stage further down than the form fill, which is why the first thing I ask for is not a budget but read access to what happens to leads after they arrive. The feedback loop: Lead outcomes return to the source within seventy-two hours, per sub-source, mapped out of Salesforce or HubSpot: contacted, qualified, disqualified with a reason, closed. Sources are then repriced against the stage that matters to you. Without that loop a lead buy optimises toward whoever produces the cheapest form fill, which is reliably the source with the least intent. Building the loop is usually a week of work with your revenue operations person, and I will not start buying before it exists. Consent and its proof: Every lead arrives with proof attached to the record rather than asserted in a contract: a TrustedForm certificate or a Jornaya token on United States buys, the captured consent language and timestamp elsewhere, and under GDPR the lawful basis plus the exact wording the person saw. Certificates are spot-checked by replaying them, not trusted, because a certificate that will not replay is the same as none. Leads without retrievable proof are returned unpaid, and that clause is in every agreement I sign. Source transparency: Sub-source disclosure down to the placement on every lead, or the source is not bought. Co-registration, incentivised forms and leads sold to more than one buyer are excluded by contract, and I verify by planting seed records and watching who calls them. Returns: A written rejection set, wrong number, outside geography, duplicate inside ninety days, no consent proof, outside the qualification criteria stated in the order, with a seven day return window and monthly reconciliation. Return rates above fifteen percent for two consecutive months end the relationship rather than open a renegotiation. Vertical rules: In recruiting, candidate data goes into your applicant tracking system under your own privacy notice. I do not buy candidate lists, scraped profiles, or records collected under a different employer's notice. In legal intake, shared leads are excluded and time to first contact is written into the buy, because intake answering in minutes converts differently from intake answering the next day. In medtech and patient-facing work, I will not buy a lead whose fields indicate a health condition. That is special-category data under GDPR Article 9 and protected health information in the United States, and no supplier assurance makes buying it safe. Not included: Media spend. Intake staffing, though I will specify what the script has to capture and how fast it has to run. Nurture email and CRM sequences after the lead lands. Any forecast of your close rate, which depends on people I do not manage. Who should not buy this: Companies that cannot report lead outcomes by source. That is not a prerequisite I can waive, it is the mechanism itself. Buyers who need volume this quarter regardless of quality, because the first thing this work does to a programme is usually reduce volume. And anyone attracted to leads other buyers are also buying because they are cheaper. They are cheaper for a reason, and in these verticals the reason is the one regulators eventually call about.